The TECTONIC Coronary Artery Disease (CAD) Intravascular Lithotripsy (IVL) clinical trial will enroll up to 335 people in 47 sites in the U.S. Coronary Artery Disease (CAD) is the most common ...

Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed, investigational system that aims to fracture hardened calcium within ...

The North-Chicago based company announced today that the U.S. Food & Drug Administration gave investigational device exemption to Abbott's coronary intravascular lithotripsy system. The trial will ...

Abbott announced that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to evaluate the treatment ...